Clinical Trial Update: LRFN5 and OLFM4 in Schizophrenia

View source ↗

Summary

The clinical trial examining LRFN5 and OLFM4 in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Elazığ Mental Health and Diseases Hospital | Conditions: Schizophrenia Disorder | Status: COMPLETED